Based on our advanced algorithm, we predict that VYNE stock price will experience significant movement in the coming periods. Our 1-day prediction estimates a price of $0.3546, while the 1-week outlook suggests a value of $0.3558. For the 1-month forecast, we project a price of $0.3419. Looking further ahead, our 2026 projection estimates a value of $1.42, with a long-term 2030 forecast reaching $4.66. Stay informed and make strategic decisions with our data-driven insights!
Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. VYNE has several positive signals and is within a rising trend, so we believe it will perform strongly in the next couple of days or weeks. We therefore hold a positive evaluation of this stock. Our analysis conclusion for this stock is a Strong Buy candidate.
VYNE stock price ended at $0.3475 on Tuesday, after rising2.05%
The Vyne Therapeutics Inc stock price increased by 2.05% on the last trading day (12 Aug 2025), rising from 0.335 to 0.3475. Throughout the last trading session, the stock experienced a fluctuation of 5.45% , ranging from a day low of $0.33 to a day high of 0.348. The price has declined in 6 of the last 10 days, resulting in a total change of -75.87% during this period. On the last day, trading volume increase by -595.33K shares, with the rising prices. This could serve as an early warning, indicating that risk may slightly increase in the coming days. In total, 1.43M shares were traded, amounting to approximately 480.00K.
VYNE Technical Signals
VYNE(Vyne Therapeutics Inc Corp) has 4 buy signals and 3 sell signals now. The current trend is downtrend starting from 2025-07-28. The total price change during this trend is -76.03%. Recently, the price has increased but the volume has decreased, indicating a potential warning signal. The average turnover of VYNE over the last 5 trading days is 999.08K. Overall, the technical indicator signals lean more toward a Neutral outlook in the mid-term.
Vyne Therapeutics Inc's overall moving average trend leans more bearish as of Wednesday, August 13, 2025, with 4 negative signals and 0 positive signal. In the mid-term, the SMA_20 being below the SMA_60 signals a strong bearish trend. There will be some resistance from the lines at $0.45, and $0.49. A break-up above any of these levels will issue buy signals. There will be some support from the lines at $0.31, and $0.26. A break-down below any of these levels will issue sell signals.
VYNE Short Selling Analysis
The short sale ratio of Vyne Therapeutics Inc(VYNE) as of 11 Aug 2025 is 29.97%, dropping from last trading day. With decreasing price from 0.36 to 0.34. The short sell activity indicate that short sellers may be anticipating price hit a bottom.
Technical Signal
Technical Signals Summary
Neutral
Sell
3
Buy
4
Moving Average
Swing
Negative
Stock Price Below SMA_5
Short Term
Negative
SMA_5 Below SMA_20
Mid Term
Negative
SMA_20 Below SMA_60
Long Term
Negative
SMA_60 Below SMA_200
Short Selling
Close Price
Short Sale Ratio
Short Sale Volume
4 Bullish Signals
4 Bullish Signals
When Value satisfies Signal, Indicator signals Bullish
Indicators
Signal
Value
Meaning
Relative Strength Index (14 days)
RSI_14 < 30
29.245
Bullish
Stochastic Oscillator %K (14, 3, 3)
STOCHk_14_3_3 < 20
1.328
Bullish
Stochastic RSI %K (14, 14, 3, 3)
STOCHRSIk_14_14_3_3 < 20
2.343
Bullish
Williams %R (14 days)
WILLR_14 < -80
-98.617
Bullish
3 Bearish Signals
3 Bearish Signals
When Value satisfies Signal, Indicator signals Bearish
In 2026, Vyne Therapeutics Inc (VYNE) is anticipated to change hands in a trading channel between $0.91 and $1.73.
Vyne Therapeutics Inc Stock Forecast 2026
Jan 2026: VYNE Stock Forecast
Potential ROI: -10.56%
In Jan 2026, Vyne Therapeutics Inc's value is forecasted to reach an average price of $1.23. The price is predicted to fluctuate between a low of $1.10 and a high of $1.33.
Feb 2026: VYNE Stock Forecast
Potential ROI: 10.47%
In Feb 2026, Vyne Therapeutics Inc's value is forecasted to reach an average price of $1.51. The price is predicted to fluctuate between a low of $1.28 and a high of $1.68.
Mar 2026: VYNE Stock Forecast
Potential ROI: 1.34%
In Mar 2026, Vyne Therapeutics Inc's value is forecasted to reach an average price of $1.39. The price is predicted to fluctuate between a low of $1.13 and a high of $1.56.
Apr 2026: VYNE Stock Forecast
Potential ROI: 11.11%
In Apr 2026, Vyne Therapeutics Inc's value is forecasted to reach an average price of $1.52. The price is predicted to fluctuate between a low of $1.45 and a high of $1.73.
May 2026: VYNE Stock Forecast
Potential ROI: -10.25%
In May 2026, Vyne Therapeutics Inc's value is forecasted to reach an average price of $1.23. The price is predicted to fluctuate between a low of $1.20 and a high of $1.38.
Jun 2026: VYNE Stock Forecast
Potential ROI: -16.46%
In Jun 2026, Vyne Therapeutics Inc's value is forecasted to reach an average price of $1.14. The price is predicted to fluctuate between a low of $0.91 and a high of $1.17.
Jul 2026: VYNE Stock Forecast
Potential ROI: -4.64%
In Jul 2026, Vyne Therapeutics Inc's value is forecasted to reach an average price of $1.31. The price is predicted to fluctuate between a low of $1.09 and a high of $1.35.
Aug 2026: VYNE Stock Forecast
Potential ROI: 3.38%
In Aug 2026, Vyne Therapeutics Inc's value is forecasted to reach an average price of $1.42. The price is predicted to fluctuate between a low of $1.37 and a high of $1.67.
Sep 2026: VYNE Stock Forecast
Potential ROI: -10.59%
In Sep 2026, Vyne Therapeutics Inc's value is forecasted to reach an average price of $1.22. The price is predicted to fluctuate between a low of $1.19 and a high of $1.30.
Oct 2026: VYNE Stock Forecast
Potential ROI: -2.29%
In Oct 2026, Vyne Therapeutics Inc's value is forecasted to reach an average price of $1.34. The price is predicted to fluctuate between a low of $1.30 and a high of $1.62.
Nov 2026: VYNE Stock Forecast
Potential ROI: -16.46%
In Nov 2026, Vyne Therapeutics Inc's value is forecasted to reach an average price of $1.14. The price is predicted to fluctuate between a low of $1.02 and a high of $1.40.
Dec 2026: VYNE Stock Forecast
Potential ROI: -16.46%
In Dec 2026, Vyne Therapeutics Inc's value is forecasted to reach an average price of $1.14. The price is predicted to fluctuate between a low of $1.13 and a high of $1.15.
VYNE Price Prediction & Forecast by Similar Chart Analysis
Based on historical patterns and backtesting of stocks with similar movements to Vyne Therapeutics Inc(VYNE), our algorithm predicts VYNE's 1-month price at $0.37, with an 3.49%upwardshift. Using a similarity score up to 98.50%and other factors, This forecast updates weekly, adjusting for significant deviations.
Similar Chart
The price prediction chart for Vyne Therapeutics Inc (VYNE.O) stock, as of Sunday, August 10, 2025 , forecasts a 3.49% change over the next month, based on its high correlation with USM.N stock patterns. The similarity between their price movements over the analyzed periods is 98.5%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.
Based on VYNE's historical stock price data across all years, the probability of a positive return in August is10.00%, suggesting it maynotbe an ideal month to invest in VYNE. In contrast,Octoberoffers the highest probability of positive returns at44.44%, making it a potentially strong month for investment.
However, this is only a prediction based on one method, and a comprehensive assessment of the stock's future trend should consider additional factors. Our final stock price commentary incorporates three main evaluation dimensions: technical signals, Moving Average trends, and similar chart pattern matching, with the first two dimensions carrying the primary weight to ensure a more robust and accurate forecast.
Monthly Seasonality
The radar chart shows that buying Vyne Therapeutics Inc (VYNE.O) stock in October has the highest probability of a positive return (44.44%), while June has the lowest probability (9.09%).
Performance Seasonality
The chart shows Vyne Therapeutics Inc. (VYNE)'s annual stock price return for the past three years, helping you analyze price trends and identify recurring trends on an annual basis.
Should I buy Vyne Therapeutics Inc (VYNE.O) stock?
Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. VYNE has several positive signals and is within a rising trend, so we believe it will perform strongly in the next couple of days or weeks. We therefore hold a positive evaluation of this stock. Our analysis conclusion for this stock is a Strong Buy candidate.
Which months have the highest win rate for buying Vyne Therapeutics Inc (VYNE.O) stock in a year?
The radar chart shows that buying Vyne Therapeutics Inc (VYNE.O) stock in October has the highest probability of a positive return (44.44%), while June has the lowest probability (9.09%).
How has Vyne Therapeutics Inc. (VYNE)'s stock price performed over the past three years?
VYNE's stock price fell by -5.52% in 2023,increased by 46.93% in 2024, and went down by 89.56%in 2025.
Is VYNE a buy based on overall technical signals summary?
VYNE has 4 buy signals and 3 sell signals now. Overall the technical rating for VYNE is Neutral . Note that market conditions change all the time. In addition to technical ratings, keep an eye on the Valuation Level of VYNE.
What is the trend of Vyne Therapeutics Inc (VYNE)'s moving average?
Vyne Therapeutics Inc's overall moving average trend leans more bearish as of August 13 2025, with 4 negative signals and 0 positive signal.
What is price prediction for VYNE stock next month?
The price prediction chart for Vyne Therapeutics Inc (VYNE.O) stock, as of August 10 2025, forecasts a 3.49% change over the next month, based on its high correlation with USM stock patterns. The similarity between their price movements over the analyzed periods is 98.5%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.
What is price prediction 2025 for VYNE Stock?
VYNE stock is predicted to trade between $0.40 and $0.60 by year-end 2025, driven by potential technical rebound and oversold conditions. However, if support levels fail, it could drop to $0.20. The stock's low price and high volatility make it speculative.
What is price prediction 2030 for VYNE Stock?
### **Price Prediction for VYNE Stock by 2030**
Based on current trends and analysis, here is a concise price prediction for VYNE stock by 2030:
1. **Bullish Scenario**: VYNE stock could reach **$5.00** by 2030 if the company successfully resolves the FDA clinical hold on VYN202 and achieves positive results from its Phase 2b trial of repibresib gel for vitiligo.
2. **Bearish Scenario**: The stock may trade around **$1.00** if the clinical hold persists and other pipeline developments face setbacks.
3. **Base Case**: A realistic target is **$3.50** by 2030, driven by moderate success in its pipeline and recovery from recent setbacks.
**Reasons**:
- The stock is currently oversold with an RSI of 31.06, indicating potential rebound potential.
- The FDA clinical hold on VYN202 has weighed heavily on the stock, but the ongoing Phase 2b trial for repibresib gel could drive recovery if results are positive.
- VYNE's forward P/S ratio of 27.77 suggests high expectations for future growth, but execution is critical.